| http://www.w3.org/ns/prov#value | - nts are desperately needed, so it is especially pleasing that patients will now be able to benefit from a drug that we helped develop.The success of vemurafenib demonstrates the importance of our approach to developing personalised medicines for cancer.Understanding the genetic and molecular causes of cancer helps us to create new, targeted therapies that - as this drug shows - can prove extremel
|
